WUXI Series Prosper

Pharmas also outperformed the market. $WUXI XDC(02268.HK)$ surged 10.1% after it expected an increase of over 80% in net profit in 2023. Same series $WUXI BIO(02269.HK)$ and $WUXI APPTEC(02359.HK)$ rebounded 5.6% and 4.6%.